We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Viking Therapeutics Inc
30 own
32 watching
Current Price
$22.28
$0.31
(1.41%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,767.23M
52-Week High
25.7199
52-Week Low
2.02
Average Volume
1.67M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,767.23M52-Week High25.719952-Week Low2.02Average Volume1.67MDividend Yield--P/E Ratio--What does the Viking Therapeutics Inc do?
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for metabolic and endocrine disorders. Its lead clinical program includes VK0612, an orally available drug candidate for the treatment of type 2 diabetes. The company is also developing VK5211, an orally available drug candidate, which is in a Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. In addition, it is developing VK0214, a novel liver-selective thyroid hormone receptor beta agonist for lipid disorders, such as dyslipidemia and nonalcoholic steatohepatitis, as well as VK2809, an orally available, tissue, and receptor-subtype selective agonist of the thyroid beta receptor that is entering Phase II development for the treatment of patients with hypercholesterolemia and fatty liver disease. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
Read More
How much money does Viking Therapeutics Inc make?
News & Events about Viking Therapeutics Inc.
PR Newswire
2 months ago
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock PR Newswire SAN DIEGO, March 29, 2023 SAN DIEGO, March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ('Viking"...
Fool.com Headlines
2 months ago
The clinical-stage stock nearly doubled in price.Shares of Viking Therapeutics (NASDAQ: VKTX) were up 89.7% for the week as of Thursday afternoon, after being up as much as 95.5% for the week, according to data provided byS&P Global Market Intelligence. The move up was largely due to positive early ...
Benzinga
3 months ago
read more...
PR Newswire
4 months ago
Viking Therapeutics Announces Completion of Enrollment in Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) Viking Therapeutics Announces Completion of Enrollment in Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic...
PR Newswire
5 months ago
Thinking about buying stock in AMC Entertainment, TAL Education, Omeros Corp, Acer Therapeutics, or Viking Therapeutics? Thinking about buying stock in AMC Entertainment, TAL Education, Omeros Corp, Acer Therapeutics, or Viking Therapeutics? PR Newswire NEW YORK, Dec. 23, 2022 NEW YORK, Dec. 23...
Frequently Asked Questions
Frequently Asked Questions
What is Viking Therapeutics Inc share price today?
Can Indians buy Viking Therapeutics Inc shares?
How can I buy Viking Therapeutics Inc shares from India?
Can Fractional shares of Viking Therapeutics Inc be purchased?
What are the documents required to start investing in Viking Therapeutics Inc stocks?
What is today’s traded volume of Viking Therapeutics Inc?
What is today’s market capitalisation of Viking Therapeutics Inc?
What is the 52-Week High and Low Range of Viking Therapeutics Inc?
What percentage is Viking Therapeutics Inc down from its 52-Week High?
What percentage is Viking Therapeutics Inc up from its 52-Week Low?
Current Price
$22.28
$0.31
(1.41%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.